Patients with systemic lupus erythematosus with a history of cutaneous lupus erythematosus are more likely to have high ...

Magnetic resonance imaging (MRI) findings such as inflammatory-type lesions and myelopathies are significantly associated with attribution of neuropsychiatric (NP) events to systemic lupus ...

A 35-year-old man presents with a chief complaint of purple discoloration of his toes and associated skin lesions that have been present for the past month.

Lupus, an autoimmune disorder, presents skin manifestations like the butterfly rash, often mimicked by conditions such as rosacea, seborrheic dermatitis, dermatomyositis, psoriasis and solar urticaria ...

Therapeutic agents targeting BAFF and/or APRIL have demonstrated promising clinical potential in systemic lupus erythematosus (SLE), lupus nephritis (LN), and other B cell-related diseases; however, ...

D-dimer assays are used as a tool to rule out thrombosis in symptomatic patients with lupus, but could they also be used to initiate preventive anticoagulation in asymptomatic patients?

From subtle rashes to sun-safety strategies, Drs Maureen McMahon and John Edminister discuss how to recognize cutaneous lupus and protect patients from UV-triggered flares.

Lupus is generally not deadly and thanks to advancements in medicine, lupus life expectancy for 80% to 90% of those diagnosed is an average lifespan with proper treatment and follow-up care. There is ...

Oral mucosal lesions present significant therapeutic challenges due to the complex oral environment and limitations of conventional biomaterials in clinical application. In this study, we introduced ...

Topical calcineurin inhibitors in cutaneous lupus erythematosus In the management of cutaneous lupus erythematosus (CLE), topical calcineurin inhibitors have recently been established as the ...